1. WHO, Towards Universal Access: Scaling up Priority HIV/AIDS Interventions in the Health Sector, 2010.
2. UNAIDS, Global Report: UNAIDS Report on the Global AIDS Epidemic 2012, 2012.
3. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women;Abdool;Science,2010
4. Microbicide Trial Network, MTN Statement on Decision to Discontinue Use of Tenofovir Gel in VOICE, A Major HIV Prevention Study in Women, 2011.
5. J.M. Marrazzo, G. Ramjee, G. Nair, T. Palanee, B. Mkhize, C. Nakabbiito, M. Taljaard, J. Piper, K. Gomez Feliciano, M. Chirenje, Pre-exposure prophylaxis for HIV in women: daily oral tenofovir, oral tenofovir/emtricitabine, or vaginal tenofovir gel in the VOICE study (MTN-003), in: Conference on Retroviruses and Opportunistic Infections, Atlanta, GA, 2013.